Peer-Reviewed Publications


  • Feldman EA, Miller CD, Wojnowicz S, Seabury R. Significant hyperbilirubinemia and acute hepatocellular jaundice in a pediatric patient receiving deferasirox: a case report. J Pediatr Pharmacol Ther. 2017. [Epub ahead of print].
  • Gill D, Feldman EA, Liu K. Evaluation of medication compliance for secondary prevention of acute coronary syndrome. Proc (Bayl Univ Med Cent). 2017. [Epub ahead of print].
  • Gill D, Schrader J, Kelly M, Martinez F, Syed W, Wright. Gemcitabine associated pseudocellulitis: A missed diagnosis. J Oncol Pharm Pract. 2017. [Epub ahead of print].
  • Hale CM, Steele JM, Seabury RW, Miller CD. Characterization of drug-related problems occuring in patients receiving outpatient antimicrobial therapy. J of Pharm Practice. 2017. [Epub ahead of print].
  • Krasniak A, Darko W, Miller CD, Seabury R, Probst LA. Changes in pharmacy residency training design between 2012 and 2017: A perspective of academic medical centers. Hosp Pharm. 2017. [Epub ahead of print].
  • Kufel WD, Miller CD, Johnson PR, Reid K, Zahra JJ, Seabury RW. Y-site incompatibility between premix concentrations of vancomycin and piperacillin-tazobactam: Do current compatibility testing methodologies tell the whole story? Hosp Pharm. 2017; 52(2): 132-137.
  • Kufel WD, Seabury RW, Darko W, Probst LA, Miller CD. Clinical feasibility of monitoring enoxaparin anti-Xa concentrations: Are we getting it right? Hosp Pharm. 2017;52(3):214-220.
  • Kufel WD, Seabury RW, Meola GM, Darko W, Probst LA, Miller CD. Impact of premix antimicrobial preparation and time to administration in septic patients. CJEM. 2017. [Epub ahead of print]. 
  • Lorenzo MP, MacConaghy L, Miller CD, Meola G, Probst LA, Pratt B, Steele J, Seabury RW. Impact of a combination antibiotic bag on compliance with surviving sepsis campaign goals in emergency department patients with severe sepsis and septic shock. Ann Pharmacother. 2017. [Epub ahead of print].
  • Mogle BT, Seabury RW, Jennings S, Cwikla GM. Severe neutrophilic dermatosis following submental deoxycholic acid administration. Clin Toxicol. 2017. [Epub ahead of print].
  • Probst LA, Welch TR. Pediatric drug formulations – unintended consequences of legislation. N Engl J Med. 2017; 376: 795-796.
  • Rose P, Seabury R, Cwikla G. Acutre hepatocellular juandice after dofetilide initiation: A case report. Hosp Pharm. 2017. [Epub ahead of print].
  • Seabury RW, Stoessel AM, Steel JM. Vancomycin trough concentration poorly characterizes AUC: Is it time to transition to AUC-based vancomycin monitoring? Annals of Pharmacotherapy. June, 2017. [Epub ahead of print].
  • Steele JM, Seabury RW, Hale CM, Mogle BT. Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin. J Clin Pharm Ther. 2017. [Epub ahead of print].



  • Hale CM, Seabury RW, Steele JM, Darko W, Miller CD. Are Vancomycin Trough Concentrations of 15-20 mg/dL Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Injection? Journal of Pharmacy Practice. 2016. [Epub ahead of print].
  • Kufel WD, Hale CM, Sideman EF, Orellana CE, Miller CD. Nucleoside Reverse Transcriptase Inhibitor (NRTI) Associated Macrocytosis. International Journal of Virology and AIDS. 2016; 3(18).
  • Kufel WD, Scrimenti A, Steele JM. A case of septic shock due to Serratia marcescens pyelonephritis and bacteremia in a patient receiving empagliflozin. J Pharm Pract. 2016. [Epub ahead of print].
  • Kufel WD, Zayac AS, Lehmann DF, Miller CD. Clinical application and pharmacodynamic monitoring in a patient with end-stage renal disease requiring chronic hemodialysis. Pharmacotherapy. 2016. 35(11):e166-e171
  • Phillips E, Saseen JJ. Current controversies with recent cholesterol treatment guidelines. J Pharm Pract. 2016. 29(1):15-25.
  • Sigona NS, Steele JM, Miller CD. Impact of a pharmacist-driven beta-lactam allergy interview on inpatient antimicrobial therapy: A pilot project. Journal of the American Pharmacist Association. 2016. [Epub ahead of print].
  • Stambough M, Roman M, Blair DC, Sidman EF, Miller CD. Preemptive antiretroviral therapy modifications for the management of potentially clinically significant drug interactions with direct acting hepatitis C therapies. Int J STD AIDS. 2016; 27(3):235-7.
  • Wills B, Darko W, Seabury R, Probst LA, Miller CD, Cwikla GM. Pharmacy impact on medication reconciliation in the medical intensive care unit. J of Research in Pharmacy Practice. 2016;5(2):142-5.


  • Noviasky J, Darko W, Akajabor D, Makaron A, Miller C, Pierce D, Seabury R, Whalen K. Digoxin (Textbook Chapter). Casebook in Clinical Pharmacokinetics, 1st Edition. Henry Cohen, editor, McGraw Hill; 2015


  • Francois D, Roberts J, Hess S, Probst L, Eksioglu Y. Medical management with diazepam for electrical status epilepticus during slow wave sleep in children. Pediatr Neurol. 2014;50(3):238-42.
  • Noviasky J, Pierce DP, Whalen K, Guharoy R, Hildreth K.  Bupivacaine Liposomal Versus Bupivacaine: Comparative Review. (Response) Hosp Pharm 2014;49(9);793-795
  • Noviasky J, Pierce DP, Whalen K, Guharoy R, Hildreth K. Bupivacaine Liposomal Versus Bupivacaine: Comparative Review. Hosp Pharm 2014;49(6):539-543
  • Patel N, Nasiri M, Koroglu A, Amin R, McGuey L, McNutt LA, Roman M, Miller CD. Prevalence of drug-drug interactions upon addition of simeprevir- or sofosbuvir-containing treatment to medication profiles of patients with HIV and hepatitis C coinfection. AIDS Res Hum Retroviruses. 2014; 372(6): 528-36.
  • Sidman E, Probst LA, Darko W, Miller CD. Evaluation of Dabigatran Utilization and Risk Among Hospitalized Patients. Ann Pharmacother. 2014; 48(3):349-53.


  • Guharoy R, Noviasky J, Haydar Z, Fakih MG, Hartman C. Compounding Pharmacy Conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm. Chest 2013 Apr;143:896-900 


  • Noviasky J, Kelberman M. Nesiritide. Were the signals missed amid the marketing? Cardiology Today July 2012
  • Shaifali S, Karachiwala H, Noviasky J, Wong D, Elliott WC, Lehmann D. To bind or to let loose: Effectiveness of sodium polystyrene sulfonate in decreasing serum potassium. 2012 Inter J Nephrology Article ID 940320
  • Suryadevara M, Steidl KE, Probst LA, Shaw J. Inappropriate vancomycin therapeutic drug monitoring in hospitalized pediatric patients increases pediatric trauma and hospital costs. J Pediatr Pharmacol Ther. 2012; 17(2):159-65.


  • Burchett DK, Darko W, Zahra J, Noviasky J, Probst L, Smith A. Mixing and compatibility guide for commonly used aerosolized medications. Am J Health Syst Pharm. 2010;67(3):227-30.
  • Steidl KE, Darko W. Probst LA, Noviasky JA, Nasser S. Rhabdomyolysis associated with phentermine. Am J Health Syst Pharm. 2010;67(22):1929-32.